KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Asset Writedowns and Impairment (2022 - 2025)

Amgen has reported Asset Writedowns and Impairment over the past 4 years, most recently at $400.0 million for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment rose 555.74% year-over-year to $400.0 million; the TTM value through Mar 2026 reached $400.0 million, down 55.11%, while the annual FY2025 figure was $1.2 billion, 654.72% up from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $400.0 million at Amgen, down from $800.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $851.0 million in Q4 2023 and troughed at $2.0 million in Q4 2022.
  • A 4-year average of $277.1 million and a median of $64.5 million in 2024 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 42450.0% in 2023 and later tumbled 96.47% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $2.0 million in 2022, then surged by 42450.0% to $851.0 million in 2023, then tumbled by 96.47% to $30.0 million in 2024, then soared by 1233.33% to $400.0 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for AMGN at $400.0 million in Q3 2025, $800.0 million in Q1 2025, and $30.0 million in Q4 2024.